StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$27.12−2.42 (-8.19%)

Close on Nov 16, 2026Market cap $1.06BP/E –Yield –

Alto Neuroscience total assets

Total assets on the balance sheet at the end of each period.

Alto Neuroscience's total assets was $326.51M at Sep 30, 2026. For fiscal 2025 it was $184.69M, up 4.0% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$184.69M+4.0%
FY2024Dec 31, 2024$177.54M+104.9%
FY2023Dec 31, 2023$86.63M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$326.51M+122.1%
Q2 FY2026Jun 30, 2026$254.07M+60.9%
Q1 FY2026Mar 31, 2026$276.26M+60.7%
Q4 FY2025Dec 31, 2025$184.69M+4.0%
Q3 FY2025Sep 30, 2025$147.01M-23.3%
Q2 FY2025Jun 30, 2025$157.88M-20.0%
Q1 FY2025Mar 31, 2025$171.92M-18.1%
Q4 FY2024Dec 31, 2024$177.54M+104.9%
Q3 FY2024Sep 30, 2024$191.61M–
Q2 FY2024Jun 30, 2024$197.36M–
Q1 FY2024Mar 31, 2024$209.92M–
Q4 FY2023Dec 31, 2023$86.63M–

More Alto Neuroscience figures

See a number that looks wrong?